NCT00019773View on ClinicalTrials.gov

Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Conditions
Carcinoma of the AppendixColorectal CancerSmall Intestine Cancer
Interventions
DRUG

capecitabine

DRUG

oxaliplatin

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00019773 - Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer | Biotech Hunter | Biotech Hunter